Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 EV-to-FCF is 2,528.65 as of Jul. 16, 2026. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.50 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 413 Medical Devices & Instruments companies, KMS Medisurgi ranks worse than 99.27% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, KMS Medisurgi's Enterprise Value is ₹434.9 Mil.
KMS Medisurgi's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.2 Mil. Therefore, KMS Medisurgi's EV-to-FCF for today is 2,528.65.
The historical rank and industry rank for KMS Medisurgi's EV-to-FCF or its related term are showing as below:
BOM:540468'
s EV-to-FCF Range Over the Past 10 Years
Min: -193.28 Med: -7.43 Max: 2528.65
Current: 2528.65
During the past 13 years, the highest EV-to-FCF of KMS Medisurgi was 2528.65. The lowest was -193.28. And the median was -7.43.
BOM:540468's EV-to-FCF is ranked worse than 99.27% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.72
vs BOM:540468: 2528.65
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
KMS Medisurgi's PE Ratio (TTM) for today is calculated as:
KMS Medisurgi's share price for today is ₹132.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.740.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
KMS Medisurgi EV-to-FCF Related Terms
KMS Medisurgi EV-to-FCF Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's EV-to-FCF falls into.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a EV-to-FCF of 2,528.65 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on KMS Medisurgi and its competitors. According to the industry distribution chart, KMS Medisurgi ranks #410 out of 413 companies in the Medical Devices & Instruments industry, placing it in the top 99.3%.
Is KMS Medisurgi's EV-to-FCF too high?
KMS Medisurgi's current EV-to-FCF is 2,528.65. The Medical Devices & Instruments industry median EV-to-FCF is 23.72. KMS Medisurgi's value of 2,528.65 is 10560.4% above this industry median. Based on the distribution chart, KMS Medisurgi ranks #410 out of 413 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, KMS Medisurgi has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #410 out of 413 companies for EV-to-FCF. This places KMS Medisurgi in the lower half of its industry. The industry median EV-to-FCF is 23.72. KMS Medisurgi's value of 2,528.65 is 10560.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.72, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current EV-to-FCF of 2,528.65 is 10560.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current EV-to-FCF is 2,528.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
Based on GuruFocus' analysis, KMS Medisurgi (BOM:540468) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹111.50, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current EV-to-FCF is 2,528.65 and 10560.4% above the Medical Devices & Instruments industry median of 23.72. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current EV-to-FCF is 2,528.65 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.50.
GuruFocus considers KMS Medisurgi to be Modestly Overvalued.
Key valuation signals for BOM:540468:
EV-to-FCF: 2,528.65
GF Value™: ₹111.50 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 10560.4% above the Medical Devices & Instruments median (#410 of 413)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
